The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
S. Ball, J. Vickery, J. Hobart, D. Wright, C. Green, J. Shearer, A. Nunn, Mayam Gomez Cano, D. MacManus, David J. Miller, S. Mallik, J. Zajicek
Health Technology Assessment